Viewing StudyNCT03190278

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 10:14 AM
Last Modification Date: 2024-10-26 @ 12:26 PM
Study NCT ID: NCT03190278
Status: RECRUITING
Last Update Posted: 2024-02-05
First Post: 2017-06-14
Brief Title: Study Evaluating Safety and Efficacy of UCART123v12 in Patients With RelapsedRefractory Acute Myeloid Leukemia
Sponsor: Cellectis SA
Organization: Cellectis SA
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
RelapsedRefractory Acute Myeloid Leukemia
Keywords:
Name View
Transcription Activator-Like Effector Nuclease TALEN View
Acute Myeloid Leukemia View
RelapsedRefractory Acute Myeloid Leukemia View
Chimeric Antigen Receptor T-Cell CAR-T therapy View
Allogeneic View